The current study addresses the functional status and role of the endothelin ETA receptor for renal vascular function in rabbits with and without heart failure (epinephrine-induced cardiomyopathy). Under baseline conditions, the ETA receptor antagonist BQ-123 did not change basal renal hemodynamics, but completely prevented endothelin-1 (ET-1)–induced renal vasoconstriction. In heart failure, in the presence of elevated plasma ET-1 concentrations (P <.05), renal vasoconstriction in response to exogenous ET-1 was intact. Unlike under baseline conditions, ETA receptor antagonism markedly increased renal blood flow (P <.05) and decreased renal vascular resistance (P <.05) in heart failure. The current study provides new insight into t...
Background/Aims: Endothelin (ET) has been implicated as an indirect mediator of injury following acu...
Cardiac preload reduction through venodilatation is beneficial in chronic heart failure. The recent ...
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progres...
AbstractEndothelin-1 (ET-1) is a multifunctional hormone which regulates the physiology of the cardi...
Endothelin-1 (ET-1) is known to cause a transient (1 h) pressor response. The former through the act...
Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia.Background...
Background: Previous studies have shown increases in endo-thelin (ET) concentration of plasma and re...
Over 30,000 publications have been published about the vasoconstrictor endothelin-1, which was ident...
Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interaction...
BACKGROUND: Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcircu...
Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.BackgroundIt is g...
Cyclosporine A (CsA), a widely used immunosuppressive agent, causes renal vasoconstriction and syste...
SummaryAll three members of the endothelin (ET) family of peptides, ET-1, ET-2, and ET-3, are expres...
ObjectiveThe vasoconstrictor effect of endothelins (ET) is mediated by endothelin A (ETA) and endoth...
Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcirculatory impai...
Background/Aims: Endothelin (ET) has been implicated as an indirect mediator of injury following acu...
Cardiac preload reduction through venodilatation is beneficial in chronic heart failure. The recent ...
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progres...
AbstractEndothelin-1 (ET-1) is a multifunctional hormone which regulates the physiology of the cardi...
Endothelin-1 (ET-1) is known to cause a transient (1 h) pressor response. The former through the act...
Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia.Background...
Background: Previous studies have shown increases in endo-thelin (ET) concentration of plasma and re...
Over 30,000 publications have been published about the vasoconstrictor endothelin-1, which was ident...
Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interaction...
BACKGROUND: Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcircu...
Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.BackgroundIt is g...
Cyclosporine A (CsA), a widely used immunosuppressive agent, causes renal vasoconstriction and syste...
SummaryAll three members of the endothelin (ET) family of peptides, ET-1, ET-2, and ET-3, are expres...
ObjectiveThe vasoconstrictor effect of endothelins (ET) is mediated by endothelin A (ETA) and endoth...
Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcirculatory impai...
Background/Aims: Endothelin (ET) has been implicated as an indirect mediator of injury following acu...
Cardiac preload reduction through venodilatation is beneficial in chronic heart failure. The recent ...
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progres...